Rank | Gene Set | Z-score |
---|---|---|
1 | angiotensin maturation (GO:0002003) | 9.02947438 |
2 | fat-soluble vitamin biosynthetic process (GO:0042362) | 7.12111348 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.00938776 |
4 | L-phenylalanine catabolic process (GO:0006559) | 7.00938776 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.69259800 |
6 | L-phenylalanine metabolic process (GO:0006558) | 6.69259800 |
7 | regulation of guanylate cyclase activity (GO:0031282) | 6.60308005 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.55397558 |
9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.36982747 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.16418556 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.16418556 |
12 | tryptophan catabolic process (GO:0006569) | 6.16418556 |
13 | NADH metabolic process (GO:0006734) | 6.15430014 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.93425230 |
15 | epoxygenase P450 pathway (GO:0019373) | 5.87623347 |
16 | tryptophan metabolic process (GO:0006568) | 5.81257683 |
17 | kynurenine metabolic process (GO:0070189) | 5.73844394 |
18 | lipoprotein transport (GO:0042953) | 5.73032037 |
19 | bile acid biosynthetic process (GO:0006699) | 5.62194735 |
20 | fructose metabolic process (GO:0006000) | 5.47963706 |
21 | urea metabolic process (GO:0019627) | 5.41061941 |
22 | urea cycle (GO:0000050) | 5.41061941 |
23 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.30595571 |
24 | regulation of cGMP biosynthetic process (GO:0030826) | 5.28834827 |
25 | complement activation, alternative pathway (GO:0006957) | 5.18245306 |
26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.16959678 |
27 | glyoxylate metabolic process (GO:0046487) | 5.15243352 |
28 | high-density lipoprotein particle remodeling (GO:0034375) | 5.13106808 |
29 | glycosphingolipid catabolic process (GO:0046479) | 5.08956111 |
30 | nitrogen cycle metabolic process (GO:0071941) | 5.04872796 |
31 | serine family amino acid catabolic process (GO:0009071) | 5.03937563 |
32 | protein carboxylation (GO:0018214) | 4.97139268 |
33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.97139268 |
34 | sulfur amino acid catabolic process (GO:0000098) | 4.96156744 |
35 | regulation of fibrinolysis (GO:0051917) | 4.93944791 |
36 | glycolipid catabolic process (GO:0019377) | 4.93819750 |
37 | regulation of protein activation cascade (GO:2000257) | 4.89499472 |
38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88959081 |
39 | bile acid metabolic process (GO:0008206) | 4.87961039 |
40 | negative regulation of fibrinolysis (GO:0051918) | 4.86780829 |
41 | intestinal absorption (GO:0050892) | 4.84944876 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 4.81512965 |
43 | aromatic amino acid family metabolic process (GO:0009072) | 4.79364232 |
44 | cysteine metabolic process (GO:0006534) | 4.78480948 |
45 | amino-acid betaine metabolic process (GO:0006577) | 4.69256451 |
46 | regulation of cholesterol esterification (GO:0010872) | 4.69107872 |
47 | acylglycerol homeostasis (GO:0055090) | 4.65636105 |
48 | triglyceride homeostasis (GO:0070328) | 4.65636105 |
49 | oligosaccharide catabolic process (GO:0009313) | 4.61137956 |
50 | regulation of complement activation (GO:0030449) | 4.58184506 |
51 | tyrosine metabolic process (GO:0006570) | 4.58007777 |
52 | amine catabolic process (GO:0009310) | 4.56462719 |
53 | cellular biogenic amine catabolic process (GO:0042402) | 4.56462719 |
54 | fat-soluble vitamin metabolic process (GO:0006775) | 4.52161330 |
55 | vitamin biosynthetic process (GO:0009110) | 4.51448400 |
56 | protein-lipid complex remodeling (GO:0034368) | 4.50998328 |
57 | macromolecular complex remodeling (GO:0034367) | 4.50998328 |
58 | plasma lipoprotein particle remodeling (GO:0034369) | 4.50998328 |
59 | homocysteine metabolic process (GO:0050667) | 4.50395325 |
60 | regulation of cGMP metabolic process (GO:0030823) | 4.48970717 |
61 | alpha-amino acid catabolic process (GO:1901606) | 4.48360805 |
62 | vitamin A metabolic process (GO:0006776) | 4.46460568 |
63 | reverse cholesterol transport (GO:0043691) | 4.46430849 |
64 | drug metabolic process (GO:0017144) | 4.45721875 |
65 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.44830064 |
66 | indolalkylamine metabolic process (GO:0006586) | 4.43523367 |
67 | phospholipid efflux (GO:0033700) | 4.43053640 |
68 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.42262052 |
69 | vitamin D metabolic process (GO:0042359) | 4.41765781 |
70 | diacylglycerol metabolic process (GO:0046339) | 4.38069377 |
71 | imidazole-containing compound metabolic process (GO:0052803) | 4.36046533 |
72 | heme transport (GO:0015886) | 4.32598199 |
73 | protein-lipid complex assembly (GO:0065005) | 4.31127743 |
74 | cellular glucuronidation (GO:0052695) | 4.30791946 |
75 | peptide hormone processing (GO:0016486) | 4.27340284 |
76 | adhesion of symbiont to host cell (GO:0044650) | 4.25640270 |
77 | virion attachment to host cell (GO:0019062) | 4.25640270 |
78 | plasma lipoprotein particle clearance (GO:0034381) | 4.24654933 |
79 | coenzyme catabolic process (GO:0009109) | 4.23988176 |
80 | bile acid and bile salt transport (GO:0015721) | 4.22337642 |
81 | glycine metabolic process (GO:0006544) | 4.21987464 |
82 | vitamin transport (GO:0051180) | 4.21967247 |
83 | cellular amino acid catabolic process (GO:0009063) | 4.11505814 |
84 | ceramide catabolic process (GO:0046514) | 4.10352725 |
85 | benzene-containing compound metabolic process (GO:0042537) | 4.08157508 |
86 | glycosylceramide metabolic process (GO:0006677) | 4.05992279 |
87 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.03568638 |
88 | endocrine process (GO:0050886) | 4.03568638 |
89 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.03568638 |
90 | lysine catabolic process (GO:0006554) | 4.03095025 |
91 | lysine metabolic process (GO:0006553) | 4.03095025 |
92 | ethanol oxidation (GO:0006069) | 4.02654794 |
93 | NAD biosynthetic process (GO:0009435) | 4.01947951 |
94 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00635489 |
95 | negative regulation of lipase activity (GO:0060192) | 4.00429524 |
96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93888899 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93888899 |
98 | uronic acid metabolic process (GO:0006063) | 3.92319600 |
99 | glucuronate metabolic process (GO:0019585) | 3.92319600 |
100 | L-ascorbic acid metabolic process (GO:0019852) | 3.91137146 |
101 | cholesterol efflux (GO:0033344) | 3.90876603 |
102 | serine family amino acid metabolic process (GO:0009069) | 3.90547016 |
103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89595103 |
104 | negative regulation of cholesterol transport (GO:0032375) | 3.88311038 |
105 | negative regulation of sterol transport (GO:0032372) | 3.88311038 |
106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.87712320 |
107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.87712320 |
108 | aldehyde catabolic process (GO:0046185) | 3.86678182 |
109 | quinone biosynthetic process (GO:1901663) | 3.84004572 |
110 | cellular ketone body metabolic process (GO:0046950) | 3.82942509 |
111 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.82319254 |
112 | cGMP biosynthetic process (GO:0006182) | 3.80743847 |
113 | carboxylic acid catabolic process (GO:0046395) | 3.79473021 |
114 | organic acid catabolic process (GO:0016054) | 3.79473021 |
115 | positive regulation of cGMP metabolic process (GO:0030825) | 3.79390831 |
116 | regulation of systemic arterial blood pressure (GO:0003073) | 3.78909890 |
117 | phospholipid homeostasis (GO:0055091) | 3.77781534 |
118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76385222 |
119 | fatty acid beta-oxidation (GO:0006635) | 3.73440346 |
120 | plasma lipoprotein particle assembly (GO:0034377) | 3.71866836 |
121 | fatty acid oxidation (GO:0019395) | 3.70613397 |
122 | positive regulation of lipid catabolic process (GO:0050996) | 3.68201645 |
123 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.67917245 |
124 | arginine metabolic process (GO:0006525) | 3.67172900 |
125 | sphingolipid catabolic process (GO:0030149) | 3.67165887 |
126 | acetyl-CoA metabolic process (GO:0006084) | 3.66315503 |
127 | protein activation cascade (GO:0072376) | 3.65156546 |
128 | fibrinolysis (GO:0042730) | 3.65125000 |
129 | lipid oxidation (GO:0034440) | 3.64105475 |
130 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63830166 |
131 | short-chain fatty acid metabolic process (GO:0046459) | 3.63130915 |
132 | monocarboxylic acid catabolic process (GO:0072329) | 3.61525352 |
133 | adhesion of symbiont to host (GO:0044406) | 3.61144707 |
134 | carnitine metabolic process (GO:0009437) | 3.61054042 |
135 | cellular response to nitric oxide (GO:0071732) | 3.60561280 |
136 | cofactor catabolic process (GO:0051187) | 3.60082948 |
137 | complement activation (GO:0006956) | 3.59346050 |
138 | glutamate metabolic process (GO:0006536) | 3.59273622 |
139 | serine family amino acid biosynthetic process (GO:0009070) | 3.58568885 |
140 | response to nitrosative stress (GO:0051409) | 3.57968060 |
141 | cellular modified amino acid catabolic process (GO:0042219) | 3.57739933 |
142 | valine metabolic process (GO:0006573) | 3.57724390 |
143 | fatty acid catabolic process (GO:0009062) | 3.55677025 |
144 | drug catabolic process (GO:0042737) | 3.55604357 |
145 | cholesterol homeostasis (GO:0042632) | 3.54876673 |
146 | complement activation, classical pathway (GO:0006958) | 3.54519933 |
147 | glycine transport (GO:0015816) | 3.52239092 |
148 | membrane lipid catabolic process (GO:0046466) | 3.51260088 |
149 | cobalamin metabolic process (GO:0009235) | 3.48773950 |
150 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.46549143 |
151 | vitamin transmembrane transport (GO:0035461) | 3.43627221 |
152 | cellular response to oxygen radical (GO:0071450) | 3.37429061 |
153 | removal of superoxide radicals (GO:0019430) | 3.37429061 |
154 | cellular response to superoxide (GO:0071451) | 3.37429061 |
155 | neutral amino acid transport (GO:0015804) | 3.28053523 |
156 | digestion (GO:0007586) | 3.25774817 |
157 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.21263587 |
158 | peptide catabolic process (GO:0043171) | 3.19955972 |
159 | renal system process involved in regulation of blood volume (GO:0001977) | 3.18916736 |
160 | lipoprotein metabolic process (GO:0042157) | 3.18100321 |
161 | glutathione biosynthetic process (GO:0006750) | 3.17641108 |
162 | GDP-mannose metabolic process (GO:0019673) | 3.15362134 |
163 | hormone catabolic process (GO:0042447) | 3.15036847 |
164 | glycerol metabolic process (GO:0006071) | 3.14791067 |
165 | regulation of cholesterol homeostasis (GO:2000188) | 3.14038711 |
166 | glycoside metabolic process (GO:0016137) | 3.13840128 |
167 | urate metabolic process (GO:0046415) | 3.13290577 |
168 | modified amino acid transport (GO:0072337) | 3.08262438 |
169 | glutathione metabolic process (GO:0006749) | 3.07111658 |
170 | iron coordination entity transport (GO:1901678) | 3.00407170 |
171 | very long-chain fatty acid metabolic process (GO:0000038) | 2.97227256 |
172 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.96298076 |
173 | regulation of vitamin metabolic process (GO:0030656) | 2.96284727 |
174 | glutathione derivative metabolic process (GO:1901685) | 2.95440642 |
175 | glutathione derivative biosynthetic process (GO:1901687) | 2.95440642 |
176 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.94282541 |
177 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.94282541 |
178 | alditol metabolic process (GO:0019400) | 2.93618132 |
179 | sterol homeostasis (GO:0055092) | 2.88220326 |
180 | eosinophil chemotaxis (GO:0048245) | 2.86283538 |
181 | flavonoid metabolic process (GO:0009812) | 2.86044454 |
182 | sphingomyelin metabolic process (GO:0006684) | 2.82667009 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.79032269 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.36288882 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.60395116 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99998661 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.67473298 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.09868416 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.06392628 |
8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.09334358 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.08047929 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76721186 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.10726902 |
12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.06313125 |
13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.45014714 |
14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.21496458 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20994678 |
16 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.16700976 |
17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.11305743 |
18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.09023570 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7666291 |
20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.95796961 |
21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85097890 |
22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83113013 |
23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76378998 |
24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.72546563 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71399640 |
26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.69108039 |
27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.67768134 |
28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.67266344 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66060514 |
30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65857325 |
31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.64961985 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58888748 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56636846 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55453772 |
35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55336608 |
36 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.49113594 |
37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48962858 |
38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44914247 |
39 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.44884487 |
40 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41960351 |
41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40789412 |
42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39828585 |
43 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33822371 |
44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33292574 |
45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30318416 |
46 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.28963218 |
47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28859886 |
48 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.28604396 |
49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27708311 |
50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.25526351 |
51 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25371063 |
52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24703149 |
53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23626271 |
54 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21899529 |
55 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21148828 |
56 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20619280 |
57 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.17350781 |
58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17296674 |
59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16583857 |
60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13997316 |
61 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.13090581 |
62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13028005 |
63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13000603 |
64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12444258 |
65 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11560466 |
66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10246731 |
67 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.09732926 |
68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08660826 |
69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07607233 |
70 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07540404 |
71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06801550 |
72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06761265 |
73 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06756803 |
74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06678439 |
75 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.06055417 |
76 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06048381 |
77 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05866002 |
78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03955785 |
79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.03488571 |
80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02655628 |
81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02200638 |
82 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99335998 |
83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99237466 |
84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99237466 |
85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98232978 |
86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97984767 |
87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97645771 |
88 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97563944 |
89 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97039103 |
90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96408889 |
91 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95842320 |
92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95247833 |
93 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94988216 |
94 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94925065 |
95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94588815 |
96 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.93890858 |
97 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93859680 |
98 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.93642622 |
99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93135409 |
100 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.92750816 |
101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91878860 |
102 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91688260 |
103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91501364 |
104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89337520 |
105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86790191 |
106 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85283964 |
107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84992813 |
108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84904386 |
109 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.84263407 |
110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82347964 |
111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81604116 |
112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81390455 |
113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80607477 |
114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.79854322 |
115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79802556 |
116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77323905 |
117 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76523749 |
118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75346466 |
119 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.72535332 |
120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71027492 |
121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.70997643 |
122 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.69405098 |
123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69100330 |
124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69095845 |
125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68929353 |
126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66766259 |
127 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.66509462 |
128 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.66187672 |
129 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.66021043 |
130 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.64800207 |
131 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.63791475 |
132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63117920 |
133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.63057705 |
134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62057548 |
135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62057548 |
136 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.61531107 |
137 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.61362280 |
138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.61242685 |
139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60860995 |
140 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.60530475 |
141 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60432755 |
142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60115999 |
143 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.60060820 |
144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59771681 |
145 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.59715184 |
146 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.59153381 |
147 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.58696277 |
148 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.58538002 |
149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58196897 |
150 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57746074 |
151 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.57356917 |
152 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.56315137 |
153 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.55523321 |
154 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54810882 |
155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54148210 |
156 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.52776249 |
157 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52769509 |
158 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.52696712 |
159 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.52688964 |
160 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52585412 |
161 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.51664749 |
162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51464130 |
163 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.50938340 |
164 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.50855956 |
165 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.50415207 |
166 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.50253602 |
167 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.49826601 |
168 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49488734 |
169 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.49450596 |
170 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49416293 |
171 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49408918 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.02961464 |
2 | MP0005360_urolithiasis | 6.76513479 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.08861585 |
4 | MP0005365_abnormal_bile_salt | 5.97693577 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93065110 |
6 | MP0004147_increased_porphyrin_level | 4.55841061 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.72249825 |
8 | MP0003252_abnormal_bile_duct | 3.65637322 |
9 | MP0010329_abnormal_lipoprotein_level | 3.62683475 |
10 | MP0003183_abnormal_peptide_metabolism | 3.56842049 |
11 | MP0004264_abnormal_extraembryonic_tissu | 2.95132374 |
12 | MP0003195_calcinosis | 2.77250531 |
13 | MP0010234_abnormal_vibrissa_follicle | 2.66545175 |
14 | MP0005332_abnormal_amino_acid | 2.62036190 |
15 | MP0009840_abnormal_foam_cell | 2.57873212 |
16 | MP0005083_abnormal_biliary_tract | 2.50985041 |
17 | MP0005670_abnormal_white_adipose | 2.35059129 |
18 | MP0001666_abnormal_nutrient_absorption | 2.25696442 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.22646057 |
20 | MP0004019_abnormal_vitamin_homeostasis | 2.20458701 |
21 | MP0002118_abnormal_lipid_homeostasis | 2.17019399 |
22 | MP0000609_abnormal_liver_physiology | 2.12256793 |
23 | MP0005058_abnormal_lysosome_morphology | 2.04034216 |
24 | MP0009697_abnormal_copulation | 2.03865200 |
25 | MP0001764_abnormal_homeostasis | 2.03451054 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.97764655 |
27 | MP0003868_abnormal_feces_composition | 1.92876902 |
28 | MP0004270_analgesia | 1.90476368 |
29 | MP0002822_catalepsy | 1.85484488 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.82371996 |
31 | MP0000372_irregular_coat_pigmentation | 1.76571555 |
32 | MP0003186_abnormal_redox_activity | 1.72965292 |
33 | MP0003011_delayed_dark_adaptation | 1.66255176 |
34 | MP0002876_abnormal_thyroid_physiology | 1.61405936 |
35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54076458 |
36 | MP0005451_abnormal_body_composition | 1.53266137 |
37 | MP0005647_abnormal_sex_gland | 1.40313691 |
38 | MP0001664_abnormal_digestion | 1.40285379 |
39 | MP0009764_decreased_sensitivity_to | 1.28218473 |
40 | MP0008260_abnormal_autophagy | 1.25868237 |
41 | MP0000678_abnormal_parathyroid_gland | 1.25436243 |
42 | MP0003724_increased_susceptibility_to | 1.24991488 |
43 | MP0000538_abnormal_urinary_bladder | 1.24942768 |
44 | MP0005409_darkened_coat_color | 1.21931259 |
45 | MP0000490_abnormal_crypts_of | 1.20598714 |
46 | MP0002102_abnormal_ear_morphology | 1.20307575 |
47 | MP0009643_abnormal_urine_homeostasis | 1.18177931 |
48 | MP0003879_abnormal_hair_cell | 1.17010606 |
49 | MP0001986_abnormal_taste_sensitivity | 1.16884927 |
50 | MP0002971_abnormal_brown_adipose | 1.16038552 |
51 | MP0010155_abnormal_intestine_physiology | 1.13557325 |
52 | MP0004130_abnormal_muscle_cell | 1.13285424 |
53 | MP0001765_abnormal_ion_homeostasis | 1.12890751 |
54 | MP0002909_abnormal_adrenal_gland | 1.12287670 |
55 | MP0009763_increased_sensitivity_to | 1.11090387 |
56 | MP0005334_abnormal_fat_pad | 1.10523214 |
57 | MP0006036_abnormal_mitochondrial_physio | 1.09632468 |
58 | MP0000598_abnormal_liver_morphology | 1.08054744 |
59 | MP0000516_abnormal_urinary_system | 1.06544233 |
60 | MP0005367_renal/urinary_system_phenotyp | 1.06544233 |
61 | MP0005666_abnormal_adipose_tissue | 1.03938759 |
62 | MP0004381_abnormal_hair_follicle | 1.02938386 |
63 | MP0008469_abnormal_protein_level | 1.02881064 |
64 | MP0003136_yellow_coat_color | 1.00004907 |
65 | MP0002254_reproductive_system_inflammat | 0.98078660 |
66 | MP0005535_abnormal_body_temperature | 0.95406131 |
67 | MP0005084_abnormal_gallbladder_morpholo | 0.94684852 |
68 | MP0001501_abnormal_sleep_pattern | 0.94633000 |
69 | MP0001661_extended_life_span | 0.92620893 |
70 | MP0002078_abnormal_glucose_homeostasis | 0.90976594 |
71 | MP0009642_abnormal_blood_homeostasis | 0.90424483 |
72 | MP0005408_hypopigmentation | 0.89926546 |
73 | MP0005501_abnormal_skin_physiology | 0.89864841 |
74 | MP0002098_abnormal_vibrissa_morphology | 0.88235790 |
75 | MP0001529_abnormal_vocalization | 0.88219309 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.87925307 |
77 | MP0004782_abnormal_surfactant_physiolog | 0.86209092 |
78 | MP0005636_abnormal_mineral_homeostasis | 0.85732612 |
79 | MP0001188_hyperpigmentation | 0.85722772 |
80 | MP0010368_abnormal_lymphatic_system | 0.85425157 |
81 | MP0009765_abnormal_xenobiotic_induced | 0.83078309 |
82 | MP0000462_abnormal_digestive_system | 0.82685567 |
83 | MP0005376_homeostasis/metabolism_phenot | 0.81442889 |
84 | MP0000566_synostosis | 0.78404212 |
85 | MP0000015_abnormal_ear_pigmentation | 0.78362300 |
86 | MP0002132_abnormal_respiratory_system | 0.73814243 |
87 | MP0004043_abnormal_pH_regulation | 0.73442928 |
88 | MP0009115_abnormal_fat_cell | 0.73223832 |
89 | MP0002938_white_spotting | 0.73047054 |
90 | MP0002090_abnormal_vision | 0.72517134 |
91 | MP0000477_abnormal_intestine_morphology | 0.72152114 |
92 | MP0003878_abnormal_ear_physiology | 0.71679847 |
93 | MP0005377_hearing/vestibular/ear_phenot | 0.71679847 |
94 | MP0005166_decreased_susceptibility_to | 0.69496254 |
95 | MP0003436_decreased_susceptibility_to | 0.68749874 |
96 | MP0006082_CNS_inflammation | 0.66693415 |
97 | MP0005257_abnormal_intraocular_pressure | 0.65428052 |
98 | MP0005266_abnormal_metabolism | 0.65201309 |
99 | MP0005075_abnormal_melanosome_morpholog | 0.64933041 |
100 | MP0003718_maternal_effect | 0.64471157 |
101 | MP0005464_abnormal_platelet_physiology | 0.64069430 |
102 | MP0005220_abnormal_exocrine_pancreas | 0.63252144 |
103 | MP0005448_abnormal_energy_balance | 0.62734571 |
104 | MP0006035_abnormal_mitochondrial_morpho | 0.61277392 |
105 | MP0001853_heart_inflammation | 0.61152829 |
106 | MP0003690_abnormal_glial_cell | 0.60053667 |
107 | MP0000013_abnormal_adipose_tissue | 0.59002302 |
108 | MP0002837_dystrophic_cardiac_calcinosis | 0.57016878 |
109 | MP0001756_abnormal_urination | 0.56921015 |
110 | MP0009333_abnormal_splenocyte_physiolog | 0.56405522 |
111 | MP0000639_abnormal_adrenal_gland | 0.54925104 |
112 | MP0009379_abnormal_foot_pigmentation | 0.54808836 |
113 | MP0001485_abnormal_pinna_reflex | 0.53793872 |
114 | MP0003953_abnormal_hormone_level | 0.53494573 |
115 | MP0005395_other_phenotype | 0.52751630 |
116 | MP0002970_abnormal_white_adipose | 0.52577253 |
117 | MP0005248_abnormal_Harderian_gland | 0.52067748 |
118 | MP0002928_abnormal_bile_duct | 0.51858672 |
119 | MP0010352_gastrointestinal_tract_polyps | 0.51532400 |
120 | MP0006292_abnormal_olfactory_placode | 0.51515278 |
121 | MP0008995_early_reproductive_senescence | 0.49379670 |
122 | MP0003866_abnormal_defecation | 0.48954733 |
123 | MP0002069_abnormal_eating/drinking_beha | 0.46431392 |
124 | MP0002693_abnormal_pancreas_physiology | 0.45577954 |
125 | MP0000537_abnormal_urethra_morphology | 0.45124748 |
126 | MP0002136_abnormal_kidney_physiology | 0.43520892 |
127 | MP0005174_abnormal_tail_pigmentation | 0.43244006 |
128 | MP0009785_altered_susceptibility_to | 0.42882178 |
129 | MP0010678_abnormal_skin_adnexa | 0.42112609 |
130 | MP0005379_endocrine/exocrine_gland_phen | 0.41690240 |
131 | MP0004185_abnormal_adipocyte_glucose | 0.39793486 |
132 | MP0002419_abnormal_innate_immunity | 0.39419431 |
133 | MP0005375_adipose_tissue_phenotype | 0.38775767 |
134 | MP0001835_abnormal_antigen_presentation | 0.38738085 |
135 | MP0001845_abnormal_inflammatory_respons | 0.37847426 |
136 | MP0000230_abnormal_systemic_arterial | 0.37543681 |
137 | MP0000604_amyloidosis | 0.37447302 |
138 | MP0003638_abnormal_response/metabolism_ | 0.37350963 |
139 | MP0005025_abnormal_response_to | 0.35606316 |
140 | MP0001881_abnormal_mammary_gland | 0.35465520 |
141 | MP0009672_abnormal_birth_weight | 0.34790766 |
142 | MP0000427_abnormal_hair_cycle | 0.33959432 |
143 | MP0008873_increased_physiological_sensi | 0.33703304 |
144 | MP0001324_abnormal_eye_pigmentation | 0.32516014 |
145 | MP0000579_abnormal_nail_morphology | 0.32326840 |
146 | MP0008872_abnormal_physiological_respon | 0.32250293 |
147 | MP0008874_decreased_physiological_sensi | 0.31619618 |
148 | MP0003959_abnormal_lean_body | 0.31458947 |
149 | MP0000249_abnormal_blood_vessel | 0.31266350 |
150 | MP0005452_abnormal_adipose_tissue | 0.30815546 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.69538430 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.59183466 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 6.59034482 |
4 | Deep venous thrombosis (HP:0002625) | 6.13852303 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.02245963 |
6 | Xanthomatosis (HP:0000991) | 5.49735440 |
7 | Hypobetalipoproteinemia (HP:0003563) | 5.45848642 |
8 | Malnutrition (HP:0004395) | 5.40460505 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.15224530 |
10 | Complement deficiency (HP:0004431) | 5.13231975 |
11 | Joint hemorrhage (HP:0005261) | 5.04496673 |
12 | Hyperglycinemia (HP:0002154) | 4.71307935 |
13 | Abnormality of vitamin B metabolism (HP:0004340) | 4.64847658 |
14 | Hyperglycinuria (HP:0003108) | 4.56793024 |
15 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.46768644 |
16 | Hyperammonemia (HP:0001987) | 4.34823193 |
17 | Epidermoid cyst (HP:0200040) | 4.32867759 |
18 | Hypolipoproteinemia (HP:0010981) | 4.28432745 |
19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19998578 |
20 | Abnormality of glycine metabolism (HP:0010895) | 4.19998578 |
21 | Widely patent fontanelles and sutures (HP:0004492) | 4.19861241 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.19673537 |
23 | Confusion (HP:0001289) | 4.11533246 |
24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06518334 |
25 | Hypoglycemic coma (HP:0001325) | 4.03734672 |
26 | Ketosis (HP:0001946) | 3.97460585 |
27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97423360 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.96609000 |
29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.95442369 |
30 | Hypoalphalipoproteinemia (HP:0003233) | 3.94637037 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.91730902 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82373120 |
33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.76288659 |
34 | Fat malabsorption (HP:0002630) | 3.74461729 |
35 | Abnormality of complement system (HP:0005339) | 3.73800461 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.67492585 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.58017217 |
38 | Hypercholesterolemia (HP:0003124) | 3.47586510 |
39 | Ileus (HP:0002595) | 3.44260365 |
40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41723365 |
41 | Abnormality of serum amino acid levels (HP:0003112) | 3.34760962 |
42 | Reticulocytopenia (HP:0001896) | 3.18925341 |
43 | Congenital sensorineural hearing impairment (HP:0008527) | 3.15767509 |
44 | Hyperbilirubinemia (HP:0002904) | 3.10757847 |
45 | Delayed CNS myelination (HP:0002188) | 3.05805810 |
46 | Chronic diarrhea (HP:0002028) | 3.05480413 |
47 | Renal cortical cysts (HP:0000803) | 3.02747438 |
48 | Dicarboxylic aciduria (HP:0003215) | 3.01330679 |
49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.01330679 |
50 | Megaloblastic anemia (HP:0001889) | 3.01175721 |
51 | Abnormality of the costochondral junction (HP:0000919) | 2.96445204 |
52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94839883 |
53 | Steatorrhea (HP:0002570) | 2.90225712 |
54 | Myocardial infarction (HP:0001658) | 2.89371374 |
55 | Systemic lupus erythematosus (HP:0002725) | 2.88687853 |
56 | Lethargy (HP:0001254) | 2.85029424 |
57 | Ketoacidosis (HP:0001993) | 2.83269432 |
58 | Abnormal urine phosphate concentration (HP:0012599) | 2.83096507 |
59 | Gout (HP:0001997) | 2.81993368 |
60 | Metabolic acidosis (HP:0001942) | 2.79785865 |
61 | Wide cranial sutures (HP:0010537) | 2.75425340 |
62 | Cerebral edema (HP:0002181) | 2.74630024 |
63 | Hyperphosphaturia (HP:0003109) | 2.71248257 |
64 | Delayed epiphyseal ossification (HP:0002663) | 2.69952116 |
65 | Hypochromic microcytic anemia (HP:0004840) | 2.67084416 |
66 | Nephrolithiasis (HP:0000787) | 2.63925533 |
67 | Hypoglycemic seizures (HP:0002173) | 2.63050123 |
68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61901876 |
69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61901876 |
70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61901876 |
71 | Hyperuricemia (HP:0002149) | 2.60630282 |
72 | Increased purine levels (HP:0004368) | 2.60630282 |
73 | Acute encephalopathy (HP:0006846) | 2.60351341 |
74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58398764 |
75 | Thin bony cortex (HP:0002753) | 2.57000286 |
76 | Spontaneous abortion (HP:0005268) | 2.55555977 |
77 | Methylmalonic aciduria (HP:0012120) | 2.55026795 |
78 | Glomerulonephritis (HP:0000099) | 2.54045008 |
79 | Generalized aminoaciduria (HP:0002909) | 2.52565329 |
80 | Vacuolated lymphocytes (HP:0001922) | 2.51683796 |
81 | Hepatocellular carcinoma (HP:0001402) | 2.48348304 |
82 | Macrocytic anemia (HP:0001972) | 2.45625847 |
83 | Abnormality of purine metabolism (HP:0004352) | 2.44538641 |
84 | Vascular calcification (HP:0004934) | 2.43754704 |
85 | Pancreatitis (HP:0001733) | 2.39236071 |
86 | Skin nodule (HP:0200036) | 2.37061797 |
87 | Hypophosphatemia (HP:0002148) | 2.35986592 |
88 | Gingival bleeding (HP:0000225) | 2.33008801 |
89 | Acute necrotizing encephalopathy (HP:0006965) | 2.31779918 |
90 | Posterior subcapsular cataract (HP:0007787) | 2.31618731 |
91 | Abnormality of magnesium homeostasis (HP:0004921) | 2.31161822 |
92 | Menorrhagia (HP:0000132) | 2.30953329 |
93 | Enlarged epiphyses (HP:0010580) | 2.30765078 |
94 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.26426001 |
95 | Acanthocytosis (HP:0001927) | 2.25965164 |
96 | Enlarged kidneys (HP:0000105) | 2.23135529 |
97 | Proximal tubulopathy (HP:0000114) | 2.22573151 |
98 | Increased CSF lactate (HP:0002490) | 2.22257448 |
99 | Metaphyseal irregularity (HP:0003025) | 2.20080342 |
100 | Opisthotonus (HP:0002179) | 2.19010399 |
101 | Hypertriglyceridemia (HP:0002155) | 2.18598839 |
102 | Vomiting (HP:0002013) | 2.17621390 |
103 | Renal tubular dysfunction (HP:0000124) | 2.14838583 |
104 | Mitochondrial inheritance (HP:0001427) | 2.14742106 |
105 | Abnormal biliary tract physiology (HP:0012439) | 2.14218023 |
106 | Bile duct proliferation (HP:0001408) | 2.14218023 |
107 | Brushfield spots (HP:0001088) | 2.12330011 |
108 | Nausea (HP:0002018) | 2.11333583 |
109 | Abnormal albumin level (HP:0012116) | 2.08745708 |
110 | Hypoalbuminemia (HP:0003073) | 2.08745708 |
111 | Cardiovascular calcification (HP:0011915) | 2.08381435 |
112 | Late onset (HP:0003584) | 2.06939836 |
113 | Elevated hepatic transaminases (HP:0002910) | 2.06373090 |
114 | Irritability (HP:0000737) | 2.04361931 |
115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04035844 |
116 | Axonal loss (HP:0003447) | 2.03954180 |
117 | Mitral stenosis (HP:0001718) | 2.01002698 |
118 | Amyloidosis (HP:0011034) | 2.00590264 |
119 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00292082 |
120 | Hydroxyprolinuria (HP:0003080) | 1.97361802 |
121 | Abnormality of proline metabolism (HP:0010907) | 1.97361802 |
122 | Glycosuria (HP:0003076) | 1.97000003 |
123 | Abnormality of urine glucose concentration (HP:0011016) | 1.97000003 |
124 | Abnormal gallbladder morphology (HP:0012437) | 1.95014407 |
125 | Hemorrhage of the eye (HP:0011885) | 1.94187199 |
126 | Neonatal onset (HP:0003623) | 1.94185323 |
127 | Hypophosphatemic rickets (HP:0004912) | 1.93307781 |
128 | Reduced antithrombin III activity (HP:0001976) | 1.92503815 |
129 | Pigmentary retinal degeneration (HP:0001146) | 1.91586332 |
130 | Progressive macrocephaly (HP:0004481) | 1.89371918 |
131 | Fair hair (HP:0002286) | 1.89141133 |
132 | Focal segmental glomerulosclerosis (HP:0000097) | 1.88924762 |
133 | Thrombophlebitis (HP:0004418) | 1.84672813 |
134 | Esophageal varix (HP:0002040) | 1.84489391 |
135 | Retinal atrophy (HP:0001105) | 1.84047690 |
136 | Hepatocellular necrosis (HP:0001404) | 1.83914884 |
137 | Hypotension (HP:0002615) | 1.83829765 |
138 | Poikilocytosis (HP:0004447) | 1.83670255 |
139 | Hyperglycemia (HP:0003074) | 1.83413388 |
140 | Cholelithiasis (HP:0001081) | 1.82895533 |
141 | Abdominal distention (HP:0003270) | 1.82328306 |
142 | Increased hepatocellular lipid droplets (HP:0006565) | 1.81878004 |
143 | Hepatic necrosis (HP:0002605) | 1.81101353 |
144 | Rickets (HP:0002748) | 1.80454986 |
145 | Symptomatic seizures (HP:0011145) | 1.79604027 |
146 | Facial shape deformation (HP:0011334) | 1.78830928 |
147 | Potter facies (HP:0002009) | 1.78830928 |
148 | Alkalosis (HP:0001948) | 1.78547677 |
149 | Cerebral palsy (HP:0100021) | 1.74290583 |
150 | Increased muscle lipid content (HP:0009058) | 1.74155030 |
151 | Abnormality of vitamin metabolism (HP:0100508) | 1.73460077 |
152 | CNS demyelination (HP:0007305) | 1.71583721 |
153 | Hyperparathyroidism (HP:0000843) | 1.68519251 |
154 | Lactic acidosis (HP:0003128) | 1.67709310 |
155 | Decreased circulating renin level (HP:0003351) | 1.65439395 |
156 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65005667 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 7.03163027 |
2 | BCKDK | 5.79674503 |
3 | IRAK3 | 3.61597620 |
4 | SIK1 | 3.51047864 |
5 | INSRR | 3.46410788 |
6 | MST4 | 3.42404303 |
7 | MAP3K12 | 3.21645553 |
8 | TAOK3 | 2.88217434 |
9 | EPHA2 | 2.78590159 |
10 | FGFR4 | 2.76344162 |
11 | MAP3K10 | 2.52528329 |
12 | PRKG2 | 2.48100314 |
13 | WNK3 | 2.47381736 |
14 | TESK2 | 2.38101535 |
15 | IRAK4 | 2.12547812 |
16 | PDK2 | 2.09288067 |
17 | PINK1 | 2.04888659 |
18 | MAP3K14 | 2.02499152 |
19 | IRAK2 | 2.00979235 |
20 | PIK3CG | 1.94397926 |
21 | ERN1 | 1.91208346 |
22 | STK16 | 1.85538247 |
23 | TAOK1 | 1.81447908 |
24 | NEK9 | 1.75828180 |
25 | ERBB4 | 1.68030535 |
26 | CAMK1D | 1.66645608 |
27 | MST1R | 1.64946510 |
28 | ZAK | 1.62113762 |
29 | STK38L | 1.58377313 |
30 | EPHA4 | 1.54855808 |
31 | IRAK1 | 1.53035254 |
32 | STK39 | 1.52049045 |
33 | TYK2 | 1.51996559 |
34 | PRKAA2 | 1.51741833 |
35 | TESK1 | 1.51732485 |
36 | FLT3 | 1.48107792 |
37 | TIE1 | 1.47999495 |
38 | EPHB2 | 1.45408157 |
39 | EIF2AK2 | 1.38260946 |
40 | TRIM28 | 1.36783368 |
41 | MAPK11 | 1.35667304 |
42 | FRK | 1.28205153 |
43 | MAP2K4 | 1.28016401 |
44 | GRK1 | 1.24742123 |
45 | NME1 | 1.22937379 |
46 | CDK19 | 1.22658711 |
47 | MAP3K11 | 1.21747356 |
48 | NLK | 1.18543759 |
49 | MAPK15 | 1.15610354 |
50 | TXK | 1.13835236 |
51 | CASK | 1.08819952 |
52 | IKBKE | 1.08107875 |
53 | MAP2K3 | 1.07684091 |
54 | TEC | 1.07292170 |
55 | ABL2 | 1.05731423 |
56 | MAP3K2 | 1.05422168 |
57 | SGK2 | 1.04013008 |
58 | OXSR1 | 1.02190455 |
59 | MAP3K5 | 1.01541875 |
60 | JAK1 | 0.99775023 |
61 | LATS1 | 0.98912444 |
62 | BRD4 | 0.98531162 |
63 | NEK1 | 0.95797857 |
64 | TGFBR2 | 0.93515110 |
65 | MAP2K7 | 0.92393911 |
66 | ADRBK2 | 0.89476306 |
67 | MUSK | 0.88748495 |
68 | PIM1 | 0.88613487 |
69 | PIK3CA | 0.87964946 |
70 | BLK | 0.87865473 |
71 | KDR | 0.87829180 |
72 | PIM2 | 0.87609176 |
73 | ICK | 0.87256159 |
74 | MATK | 0.86050499 |
75 | BUB1 | 0.84568005 |
76 | MAPK4 | 0.83969103 |
77 | DYRK3 | 0.82858363 |
78 | PRKCI | 0.82793760 |
79 | WNK4 | 0.82610208 |
80 | OBSCN | 0.81754951 |
81 | JAK2 | 0.78782145 |
82 | MAP3K4 | 0.77760696 |
83 | CAMK1G | 0.76193888 |
84 | MAP2K6 | 0.75790182 |
85 | PLK4 | 0.75781920 |
86 | DMPK | 0.74580803 |
87 | STK4 | 0.73483650 |
88 | IKBKB | 0.73201448 |
89 | EIF2AK1 | 0.73016018 |
90 | TNIK | 0.71745477 |
91 | TBK1 | 0.70569491 |
92 | AKT3 | 0.70149020 |
93 | MKNK2 | 0.69831848 |
94 | BMPR2 | 0.68731253 |
95 | KIT | 0.68065307 |
96 | CSK | 0.67520470 |
97 | NUAK1 | 0.67243449 |
98 | CDK6 | 0.66804883 |
99 | CSNK1G3 | 0.66624775 |
100 | MAP4K2 | 0.64023324 |
101 | TAOK2 | 0.63387547 |
102 | MET | 0.63234628 |
103 | PRKAA1 | 0.62543027 |
104 | SIK3 | 0.62475309 |
105 | SGK3 | 0.62341935 |
106 | FGFR3 | 0.62132952 |
107 | MAPK12 | 0.61446100 |
108 | PTK6 | 0.58964442 |
109 | MAPK7 | 0.58687986 |
110 | TNK2 | 0.57448566 |
111 | BMX | 0.57394839 |
112 | MAP3K1 | 0.57088069 |
113 | NME2 | 0.56874467 |
114 | GRK7 | 0.56345133 |
115 | CSNK1G2 | 0.55895472 |
116 | EPHA3 | 0.55658519 |
117 | CSNK1G1 | 0.54865152 |
118 | MAP3K6 | 0.54544892 |
119 | PRKCA | 0.53507593 |
120 | GRK6 | 0.52575543 |
121 | PRKACG | 0.51741331 |
122 | CDK3 | 0.51659511 |
123 | STK38 | 0.50644347 |
124 | CSF1R | 0.49895442 |
125 | DAPK3 | 0.49573021 |
126 | SRPK1 | 0.49259833 |
127 | STK24 | 0.48702550 |
128 | CAMK2G | 0.47144614 |
129 | BTK | 0.47125761 |
130 | CDK4 | 0.46774139 |
131 | CHUK | 0.46511112 |
132 | MAP3K7 | 0.45739204 |
133 | CSNK1A1L | 0.45227106 |
134 | TLK1 | 0.44654143 |
135 | DYRK1B | 0.43895279 |
136 | PRKD2 | 0.43666488 |
137 | MAP2K2 | 0.43614096 |
138 | SGK494 | 0.43060483 |
139 | SGK223 | 0.43060483 |
140 | PBK | 0.42384802 |
141 | ERBB2 | 0.41148258 |
142 | LYN | 0.41121859 |
143 | DAPK2 | 0.41086982 |
144 | YES1 | 0.40688984 |
145 | PRKCG | 0.40661620 |
146 | DDR2 | 0.40484076 |
147 | FGFR2 | 0.39602766 |
148 | MAP3K3 | 0.39549191 |
149 | IGF1R | 0.39323766 |
150 | RPS6KA5 | 0.39102216 |
151 | CDK9 | 0.38823066 |
152 | MYLK | 0.38695809 |
153 | PKN1 | 0.38459665 |
154 | JAK3 | 0.38417928 |
155 | CSNK2A1 | 0.37921525 |
156 | PAK4 | 0.37584149 |
157 | FER | 0.36394286 |
158 | NTRK3 | 0.34878603 |
159 | CAMK2D | 0.34683895 |
160 | MAP3K8 | 0.34131830 |
161 | PRKACA | 0.33682853 |
162 | RPS6KA2 | 0.30600730 |
163 | DAPK1 | 0.30286223 |
164 | PAK3 | 0.29162952 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.25547918 |
2 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.58415670 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.19228332 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.91675362 |
5 | Mineral absorption_Homo sapiens_hsa04978 | 2.71794791 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69855980 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67303337 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65836895 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61655629 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61539019 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59209273 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52017521 |
13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50481327 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44183473 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29292905 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27864578 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.27320272 |
18 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22778187 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.15245794 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05427350 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05004823 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02505431 |
23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.99233879 |
24 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97292111 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93530691 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92562836 |
27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.91440751 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.91196874 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.91040942 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89692451 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88876268 |
32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86213959 |
33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.73508883 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73373120 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61592099 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.56046931 |
37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53369203 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47738788 |
39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42290727 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41025844 |
41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39970610 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38749727 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.36851312 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35256125 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32798951 |
46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.31826582 |
47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.31464591 |
48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30850956 |
49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29558339 |
50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29478790 |
51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26313806 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17873130 |
53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17435791 |
54 | Bile secretion_Homo sapiens_hsa04976 | 1.13754461 |
55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12959060 |
56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12014937 |
57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10815528 |
58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04461538 |
59 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01842215 |
60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01058268 |
61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01018879 |
62 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00949081 |
63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97111633 |
64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96617887 |
65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95121954 |
66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93578998 |
67 | Proteasome_Homo sapiens_hsa03050 | 0.91458132 |
68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88712894 |
69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87589805 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.86087708 |
71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85128466 |
72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82798619 |
73 | Ribosome_Homo sapiens_hsa03010 | 0.80790157 |
74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80625863 |
75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73471549 |
76 | Lysosome_Homo sapiens_hsa04142 | 0.71373810 |
77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71336914 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59024084 |
79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54786258 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54088122 |
81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52662996 |
82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48240240 |
83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42461780 |
84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42193817 |
85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41206769 |
86 | RNA polymerase_Homo sapiens_hsa03020 | 0.37007420 |
87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36900190 |
88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31376839 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30301853 |
90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29553460 |
91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24261462 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22808246 |
93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21281200 |
94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20845336 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19970583 |
96 | Asthma_Homo sapiens_hsa05310 | 0.19799288 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18859726 |
98 | Prion diseases_Homo sapiens_hsa05020 | 0.18123892 |
99 | Insulin resistance_Homo sapiens_hsa04931 | 0.18015544 |
100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.17151718 |
101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.11221056 |
102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.06621874 |
103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06164329 |
104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06101966 |
105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05390745 |
106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.05268152 |
107 | Phototransduction_Homo sapiens_hsa04744 | 0.04946097 |
108 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.04375732 |
109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04226348 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -8.8939644 |
111 | Purine metabolism_Homo sapiens_hsa00230 | -0.1480254 |
112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1466241 |
113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1365506 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1248754 |
115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1245051 |
116 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1226061 |
117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1206165 |
118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1175756 |
119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1113937 |
120 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0873616 |
121 | Protein export_Homo sapiens_hsa03060 | -0.0790593 |
122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0698151 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0652928 |
124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0454218 |
125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0296783 |
126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0252363 |